Friend or Foe? An Assessment of eClinical Technologies and Industry Initiatives

Craig Morgan
Head of Marketing, Study Startup

Increasingly under pressure to reduce study timelines and costs, the pharmaceutical industry has been deploying eClinical solutions to reduce the inefficiencies in trails. Investigative sites are now inundated with technologies adding to their already heavy workload burden. However, are better technologies just part of the solution? Numerous industry initiatives are also now available to help sites improve operational efficiencies.

Faced with this myriad of options, what are the challenges and opportunities currently facing the adoption and deployment of these technologies/initiatives?

A panel of site-centric industry organizations will present and discuss the finding from a new study aimed at addressing these questions.

This webcast will focus on understanding the sites’ perspective on these issues, which is of paramount importance in guiding and sustaining global clinical research.

Please join us for this webcast:

Live: Tuesday, August 27, 2019

1pm EDT | 12pm CDT | 10am PDT

On Demand: available after airing until August 27, 2020

Register here.

This webcast will explore:

  • The impact of the ‘One and Done’ Syndrome on investigative sites
  • Study engagement trends associated with site type and location and their subsequent impact on patient enrollment
  • The impact of eClinical technology, both current and future, including consolidated investigator platforms, on the investigative site and their ability to conduct clinical trials
  • The impact of numerous site-centric industry initiatives
  • The impact of Decentralized Clinical Trials (DCTs) on investigative sites
  • Technology trends and perceptions with regards to previous research

This webcast is applicable to:

  • Investigative sites engaged or wishing to engage in clinical studies
  • Sponsor and CRO roles responsible for site identification, feasibility assessment, selection and activation
  • Sponsor and CRO roles responsible for project management of studies and operational excellence



CASEY ORVIN, President, Society for Clinical Research Sites (SCRS)

Casey Orvin is president of the Society for Clinical Research Sites (SCRS). With nearly 20 years of experience working with the site community, Orvin previously served as executive vice president of business development for Synexus, and vice president of marketing and sponsor recruitment for Clinical Research Advantage.

Orvin is a champion for clinical research sites with experience creating outreach programs, developing key partnerships, and generating study opportunities for hundreds of clinical research sites globally. He is an active community member and dedicated volunteer in the Phoenix area where he lives with his wife and three children.


JIM KREMIDAS, Executive Director, Association of Clinical Research Professionals (ACRP)

Jim is currently the Executive Director for ACRP, a not-for profit association the represents the clinical research enterprise. Prior to that he conducted consulting services for a variety of clients including support for investigator sites, academic institutions, sponsors and suppliers. He was the SVP of Patient Recruitment at two different large CROs for over 6 years where he and his team were responsible for developing and implementing patient enrollment strategies for global clinical trials. Prior to that, he spent 24 years with Eli Lilly and Company.

Jim is on the advisory board of CISCRP (a non-profit organization focused on enhancing patient participation in clinical trials) and is also a volunteer for the Clinical Trial Transformation Initiative (CTTI) with Duke and the NIH. Jim is a frequent presenter at Industry Conferences and his articles/papers have been published in a wide variety of trade journals.


JOAN CHAMBERS, VP of Marketing & Strategy, ClinX, parent company of Clin-Edge

Joan is the Vice President of Marketing and Strategy at ClinX, a global service solutions provider for research sites, patients and healthcare organizations. Prior to joining ClinX, Joan's 20+ years in the health life sciences industry includes working in senior management roles at SCORR Marketing, CenterWatch, Cambridge Healthtech Institute, Tufts Center for the Study of Drug Development at Tufts University, and PAREXEL International. Joan holds a B.S. in Marketing.

Joan is on the Board of Directors for Greater Gift, The Center for Information and Study on Clinical Research Participation (CISCRP), the US PharmaTimes Steering Committee for CROY, Steering Committee for Pharma Intelligence/Informa Clinical & Research Excellence Awards, Steering Committee for PopUp Star and is an active member of the Association of Clinical Research Professionals (ACRP) and the Drug Information Association (DIA).


ELVIN THALUND, Director, Industry Strategy, Oracle Health Sciences

Elvin is a recognized industry expert in clinical trials, having over twenty years of experience working as a Clinical Business Analyst Consultant at major pharmaceutical companies including, Hoffmann-La Roche and Johnson & Johnson. Elvin works as a product strategist and system architect in Oracle Health Sciences effort to optimize Study Startup. Elvin is the co-chair on the TMF Reference Model Exchange Mechanism and holds a Master of Science in Industrial Engineering from Aalborg Universitet.



Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.